| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Teesta Valley Tea Company Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-current Assets |
|
|
|
Property, Plant & Equipment |
1,96,885.55 |
2,00,762.17 |
|
Capital Work in Progress |
26,024.64 |
19,447.87 |
|
Intangible Assets |
23.44 |
44.51 |
|
Financial Assets |
|
|
|
Loans |
3,660.65 |
3,609.64 |
|
Other Financial Assets |
123.57 |
123.57 |
|
Non-Current Tax Assets (Net) |
1,625.43 |
2,076.19 |
|
Deferred Tax Assets (Net) |
2,844.77 |
2,501.15 |
|
Other Non-Current Assets |
260.00 |
260.00 |
|
Current Assets |
|
|
|
Inventories |
99,291.46 |
1,10,772.86 |
|
Biological Assets Other Than Bearer Plants |
67,628.18 |
67,827.60 |
|
Financial Assets |
|
|
|
Trade Receivables |
3,634.58 |
345.99 |
|
Cash & Cash Equivalents |
181.53 |
215.53 |
|
Other Bank Balances |
830.00 |
830.00 |
|
Loans |
2,151.02 |
2,151.02 |
|
Other Financial Assets |
14,791.59 |
14,790.63 |
|
Current Tax Assets (Net) |
6,863.47 |
5,739.84 |
|
Other Current Assets |
1,649.01 |
1,480.41 |
|
Total assets |
4,28,468.89 |
4,32,978.99 |
|
Equity |
|
|
|
Equity Share Capital |
1,500.00 |
1,500.00 |
|
Reserve & Surplus |
80,243.18 |
96,934.67 |
|
Non-Current Liabilities |
|
|
|
Borrowings |
16,347.08 |
11,519.33 |
|
Current Liabilities |
|
|
|
Borrowings |
1,51,057.11 |
1,47,792.13 |
|
Trade Payables |
25,107.86 |
21,028.67 |
|
Other Financial Liabilities |
9,473.91 |
7,806.92 |
|
Other Current Liabilities |
1,44,739.76 |
1,46,397.28 |
|
Total equity & liabilities |
4,28,468.89 |
4,32,978.99 |
|
Particulars |
FY 2024-25 |
FY 2023-24 |
|
Income |
|
|
|
Revenue From Operations |
1,86,354.38 |
1,39,169.17 |
|
Other Income |
736.40 |
693.94 |
|
Total Revenue |
1,87,090.78 |
1,39,863.11 |
|
Expenses |
|
|
|
Change in Inventories of Finished Goods |
12,275.13 |
-29,264.22 |
|
Change in Biological Assets |
199.42 |
-14,201.05 |
|
Employee Benefits Expenses |
1,27,969.83 |
1,31,086.89 |
|
Finance Costs |
11,971.21 |
10,044.68 |
|
Depreciation & Amortization |
3,953.80 |
4,056.67 |
|
Other Expenses |
47,756.50 |
58,291.13 |
|
Total Expenses |
2,04,125.90 |
1,60,014.09 |
|
Profit/(Loss) Before Tax |
-17,035.12 |
-20,150.98 |
|
Deferred Tax (including MAT) |
343.63 |
87.78 |
|
Profit/(Loss) for the Year |
-16,691.49 |
-20,238.76 |
|
Other Comprehensive Income |
- |
- |
|
Total Comprehensive Income for the Year |
-16,691.49 |
-20,238.76 |
|
Earnings Per Share (Basic & Diluted) |
-111.28 |
-134.33 |
|
Particulars |
FY 2024-25 |
FY 2023-24 |
|
Cash flow from operating activities |
|
|
|
Net Profit/(Loss) Before Tax |
-17,035.12 |
-20,150.98 |
|
Adjustments For: |
|
|
|
Depreciation |
3,953.80 |
4,056.67 |
|
Interest Income |
-339.44 |
-315.70 |
|
Interest Expenses |
11,971.21 |
10,044.68 |
|
Operating Profit Before Working Capital Changes |
-1,449.54 |
-6,365.00 |
|
Adjustment For: |
|
|
|
Trade & Current Receivables |
-3,458.15 |
-1,909.13 |
|
Inventories |
11,481.40 |
-27,395.27 |
|
Biological Assets |
199.42 |
-14,201.05 |
|
Trade & Current Payables |
408.87 |
40,161.18 |
|
Cash Generated from Operations |
10,861.80 |
-9,710.00 |
|
Direct Taxes Paid |
-672.86 |
-952.56 |
|
Net Cash from Operating Activities |
10,189.00 |
-10,662.17 |
|
Cash flow from investing activities |
|
|
|
Payment against acquisition of Fixed Assets |
-6,632.88 |
-8,432.69 |
|
Long Term Borrowing |
-51.02 |
-51.16 |
|
Investment Realization/(Made) |
- |
-315.13 |
|
Net Cash from Investing Activities |
-6,683.90 |
-8,798.98 |
|
Cash flow from financing activities |
|
|
|
Proceeds from Short Term Borrowings |
3,524.98 |
29,034.51 |
|
Interest Received |
339.44 |
197.61 |
|
Interest Paid |
-11,971.21 |
-9,096.59 |
|
Long Term Loan Received |
4,827.75 |
-265.46 |
|
Net Cash from Financing Activities |
-3,279.04 |
19,870.00 |
|
Net Change in Cash & Cash Equivalents |
226.00 |
408.94 |
|
Cash & Cash Equivalents (Opening Balance) |
4,809.53 |
4,400.59 |
|
Cash & Cash Equivalents (Closing Balance) |
5,035.53 |
4,809.53 |
Summary
of cash flow statement for the year 2025 and 2024:
Cash Flow from Operating Activities
The company reported
a negative profit before tax of ₹17,035
thousand in FY 2024–25, though the loss narrowed compared to ₹20,151 thousand
in the previous year. After adjusting for non-cash and financing items such as
depreciation (₹3,954 thousand) and interest expenses (₹11,971 thousand), the
operating loss reduced significantly, resulting in a smaller negative operating
profit before working capital changes.
A major improvement
came from working capital adjustments.
Inventory levels decreased sharply (₹11,481 thousand inflow), indicating better
inventory management compared to a heavy buildup last year. Biological assets
also contributed positively, unlike the previous year’s significant outflow.
Although receivables increased (cash outflow), and payables rose only
marginally, the overall working capital movement turned favorable. As a result,
cash generated from operations turned positive at
₹10,862 thousand, compared to a negative ₹9,710 thousand last
year. After paying taxes, the company reported a net positive operating cash flow of ₹10,189 thousand, marking
a strong recovery in operational cash generation despite accounting losses.
Cash Flow from Investing Activities
The investing
section shows continued cash outflows, primarily due to capital expenditure on fixed assets amounting to ₹6,633
thousand. This suggests ongoing investment in maintaining or expanding
productive capacity, though at a slightly lower level than the previous year.
There was minimal
movement in long-term borrowings and no significant investment transactions
during the year, unlike the prior year which included some investment outflow.
Overall, net cash used in investing activities stood
at ₹6,684 thousand, slightly lower than the previous year’s
₹8,799 thousand, indicating a modest reduction in capital spending intensity.
Cash Flow from Financing Activities
Financing activities
reflect a shift in the company’s funding pattern. In FY 2024–25, short-term borrowings increased modestly (₹3,525
thousand), but this is significantly lower than the large inflow seen in FY
2023–24. The company also raised long-term loans of ₹4,828
thousand, compared to a net repayment in the previous year.
However, the biggest
impact came from high interest payments (₹11,971
thousand), which outweighed inflows from borrowings and
interest income. Consequently, the company reported a net cash outflow from financing activities of ₹3,279 thousand,
in contrast to a strong inflow of ₹19,870 thousand in the previous year. This
indicates reduced reliance on external funding and a heavier burden of finance
costs.
Net Change in Cash Position
Despite positive
operating cash flow, the outflows from investing and financing activities
largely offset the gains. The company recorded only a modest net increase in cash and cash equivalents of ₹226 thousand,
compared to ₹409 thousand last year. The closing cash balance stood at ₹5,036 thousand, slightly higher than ₹4,810 thousand in
the previous year, indicating stable liquidity but limited cash accumulation.
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Current ratio |
0.65 |
0.67 |
|
Debt -
Equity Ratio |
2.75 |
5.23 |
|
Debt
Service Coverage Ratio |
-72.28 |
-6.01 |
|
Return
on Equity |
-0.19 |
-0.19 |
|
Inventory
Turnover Ratio |
1.77 |
1.43 |
|
Trade
Receivables Turnover Ratio |
93.63 |
402.24 |
|
Trade
Payables Turnover Ratio |
0.12 |
0.16 |
|
Net
Capital Turnover Ratio |
-1.40 |
-1.42 |
|
Net
Profit Ratio |
-0.09 |
-0.14 |
|
Return
on Capital Employed |
-0.04 |
-0.88 |
Summary of ratios for the year 2025 and 2024:
Current Ratio
The current ratio
slightly declined from 0.67 in 2023–24 to 0.65 in 2024–25. This indicates that
the company’s short-term liquidity position remains weak, as current
liabilities continue to exceed current assets. The marginal fall shows no
significant improvement, suggesting that the company may still face difficulty
in meeting its short-term obligations comfortably.
Debt–Equity Ratio
The debt–equity
ratio improved considerably from 5.23 to 2.75. This reflects a reduction in
financial leverage, indicating that the company has either reduced its debt
levels or strengthened its equity base. Although this is a positive sign, the
ratio is still on the higher side, implying continued reliance on borrowed
funds.
Debt Service Coverage Ratio
The DSCR worsened
significantly from -6.01 to -72.28. A negative DSCR indicates that the company
is not generating enough operating income to meet its debt servicing
requirements. The sharp decline highlights severe financial stress and raises
serious concerns about the company’s ability to sustain its debt obligations.
Return on Equity
Return on equity
remained unchanged at -0.19 in both years. This indicates that the company
continues to incur losses and is unable to generate returns for its
shareholders. The consistently negative ROE reflects ongoing erosion of
shareholder value.
Inventory Turnover Ratio
The inventory
turnover ratio improved from 1.43 to 1.77, indicating better efficiency in
managing and selling inventory. This suggests that the company has improved its
stock movement and reduced inventory holding periods, which is a positive
operational development.
Trade Receivables Turnover Ratio
The trade
receivables turnover ratio declined sharply from 402.24 to 93.63. Although
still relatively high, the decrease indicates slower collection of receivables
compared to the previous year. This may have an adverse impact on liquidity and
suggests less efficient credit management.
Trade Payables Turnover Ratio
The trade payables
turnover ratio decreased from 0.16 to 0.12, showing that the company is taking
a longer time to pay its suppliers. While this may help conserve cash in the
short term, it could also reflect financial pressure and may affect
relationships with creditors.
Net Capital Turnover Ratio
The net capital
turnover ratio remained negative, changing slightly from -1.42 to -1.40. This
indicates inefficient use of working capital, likely due to negative working
capital or continued operational losses. The minor improvement does not
significantly change the overall position.
Net Profit Ratio
The net profit ratio
improved from -0.14 to -0.09. Although still negative, this shows that the
company has reduced its losses relative to its revenue. This improvement
suggests better cost control or operational efficiency during the year.
Return on Capital Employed
ROCE improved substantially
from -0.88 to -0.04. This indicates a significant reduction in losses in
relation to total capital employed, reflecting better utilization of funds.
However, since it remains negative, the company has not yet achieved
profitability.